Preparatory Mindset
Abnormal psychology = the scientific study of psychological disorders — their definition, classification (DSM-5), causes, and treatment. This chapter consolidates the disorder-specific content (depression, anxiety, PTSD covered in Ch10) into a broad DSM-5 overview: the neurodevelopmental, psychotic, bipolar, personality, and somatic disorders plus suicide risk. The exam asks about the definition of abnormal behavior, DSM-5 classification, and the biopsychosocial model.
Exam mindset: know the 4 D's of abnormal behavior (deviance, dysfunction, distress, danger), the DSM-5 main categories, schizophrenia (positive/negative symptoms), bipolar disorder (mania), and personality disorders (Cluster A/B/C, borderline). This chapter + Ch10 covers the full disorder spectrum.
Core Concepts
1. Definition of abnormal behavior (MUST KNOW)
1. Deviance — behavior deviates from social/cultural norms 2. Dysfunction — interferes with daily functioning (occupational, social, self-care) 3. Distress — causes personal suffering 4. Danger — risk to self or others (not always present)
- The 4 D's:
- Caveat: abnormality is culturally relative — context matters (e.g., grief, religious experience)
- Statistical definition: rare behavior ≠ necessarily abnormal (high IQ is rare but not abnormal)
2. The biopsychosocial model (MUST KNOW)
- Biological: genetics, neurochemistry (dopamine, serotonin), brain structure/function, hormones
- Psychological: cognition, learning, personality, coping
- Social: stress, trauma, family, culture, socioeconomic
- Diathesis-stress model: vulnerability (diathesis) + stress → disorder
- DSM-5: the standard diagnostic manual (dimensional + categorical)
3. DSM-5 main categories (MUST KNOW)
| Category | Examples |
|---|---|
| Neurodevelopmental | ADHD, autism spectrum, intellectual disability, learning disorders |
| Schizophrenia spectrum & other psychoses | Schizophrenia, schizoaffective, delusional |
| Bipolar & related | Bipolar I/II, cyclothymia |
| Depressive | MDD, persistent depressive (dysthymia), premenstrual dysphoric |
| Anxiety | GAD, panic, phobias, separation (see Ch10) |
| Obsessive-compulsive & related | OCD, body dysmorphic, hoarding |
| Trauma & stressor-related | PTSD, acute stress, adjustment (see Ch10) |
| Somatic symptom & related | Somatic symptom disorder, illness anxiety (hypochondriasis), conversion |
| Dissociative | Dissociative identity, amnesia, depersonalization |
| Feeding & eating | Anorexia nervosa, bulimia, binge-eating |
| Sleep-wake | Insomnia, hypersomnia, narcolepsy |
| Gender dysphoria | — |
| Disruptive, impulse-control | Oppositional defiant, conduct, intermittent explosive |
| Substance-related & addictive | Alcohol, opioid, stimulant; gambling |
| Neurocognitive | Delirium, dementia (Alzheimer's, vascular) |
| Personality | Cluster A/B/C |
| Paraphilic | — |
4. Schizophrenia (MUST KNOW)
- Delusions — fixed false beliefs (persecutory, grandiose, reference, thought broadcasting) - Hallucinations — false perceptions (auditory most common; Schneiderian first-rank: voices commenting, arguing) - Disorganized speech (loose associations, neologisms) & behavior (catatonia)
- Core features: psychosis — delusions, hallucinations, disorganized speech/behavior, negative symptoms; ≥6 months (schizophreniform 1-6 months, brief psychotic <1 month)
- Positive symptoms (excess):
- Negative symptoms (deficit): avolition (loss of motivation), alogia (poverty of speech), anhedonia, flat affect, asociality — these predict poor outcome
- Cognitive symptoms: attention, memory, executive dysfunction
- Etiology: dopamine hypothesis (hyperdopaminergic in mesolimbic), genetics (heritability ~80%), neurodevelopmental, stress
- Treatment: antipsychotics (first-gen — haloperidol, chlorpromazine; second-gen — risperidone, olanzapine, clozapine for refractory), psychosocial (CBT for psychosis, family therapy, social skills), long-acting injectables for adherence
- Extrapyramidal side effects: EPS (parkinsonism, akathisia, dystonia), tardive dyskinesia; metabolic syndrome with atypical agents
- Prognosis: positive symptoms respond to medication; negative symptoms are harder to treat
5. Bipolar disorder (MUST KNOW)
- Distractibility, Insomnia (decreased need for sleep), Grandiosity, Flight of ideas, Activity (increased goal-directed), Speech (pressured), Thoughtlessness (poor judgment — spending, risky sex)
- Bipolar I: ≥1 manic episode (with or without depression)
- Bipolar II: hypomania + major depression (never full mania)
- Mania (MUST KNOW — the "DIG FAST" mnemonic):
- Hypomania: same but milder, no psychosis, no marked functional impairment, <4 days
- Treatment: mood stabilizers (lithium — first-line; valproate, lamotrigine), antipsychotics (quetiapine, olanzapine), avoid antidepressants as monotherapy (may trigger mania)
- Lithium monitoring: therapeutic level (0.6-1.2 mmol/L), toxicity (tremor, nausea, ataxia, seizures — monitor renal & thyroid)
6. Personality disorders (MUST KNOW)
- Definition: enduring, inflexible patterns of inner experience & behavior deviating from cultural expectations, causing distress/impairment (onset adolescence/early adulthood, stable)
- Cluster A (odd/eccentric): paranoid, schizoid, schizotypal
- Cluster B (dramatic/emotional): antisocial, borderline, histrionic, narcissistic
- Cluster C (anxious/fearful): avoidant, dependent, obsessive-compulsive (PD — NOT OCD)
- Borderline PD (MUST KNOW): instability of relationships, self-image, and affect; impulsivity; fear of abandonment; splitting; self-harm & suicidal behavior; emptiness; stress-related paranoia — DBT is the evidence-based treatment
- Antisocial PD: disregard for & violation of others' rights; lack of remorse; childhood conduct disorder; psychopathy (PCL-R) overlaps
- Treatment: psychotherapy (DBT for BPD, CBT, mentalization-based, schema); limited medication (symptom-targeted); prognosis guarded
7. Somatic symptom & related disorders (MUST KNOW)
- Somatic symptom disorder: physical symptoms + excessive thoughts/feelings/behaviors about them (distress out of proportion)
- Illness anxiety disorder (hypochondriasis): preoccupation with having a serious illness despite normal exams
- Conversion disorder (functional neurological): neurological symptoms (paralysis, blindness, seizures) incompatible with medical disease — la belle indifférence (indifference to symptoms)
- Factitious disorder (Munchausen): intentional production of symptoms for the sick role (vs. malingering — external gain)
- Treatment: CBT, reassurance, treat comorbidity (depression/anxiety), avoid unnecessary investigations
8. Eating disorders (MUST KNOW)
- Anorexia nervosa: restriction, low BMI (<18.5), intense fear of gaining weight, body-image distortion, amenorrhea; medical complications (bradycardia, hypothermia, osteopenia, electrolyte disturbance — refeeding syndrome!)
- Bulimia nervosa: binge-purge cycles, normal/low-normal weight, self-induced vomiting, laxative use; complications (dental erosion, esophageal tears, hypokalemia, parotid swelling)
- Binge-eating disorder: binges without purging (obesity association)
- Treatment: multidisciplinary — nutritional rehabilitation, CBT (first-line), family-based (adolescents — Maudsley), SSRIs (bulimia), refeeding cautiously (phosphate monitoring)
9. OCD & related (MUST KNOW)
- OCD: obsessions (intrusive thoughts) + compulsions (rituals to reduce anxiety); insight may be poor
- Treatment: CBT with exposure & response prevention (ERP) — first-line; SSRIs (high dose); severe → augmentation
- Body dysmorphic disorder: preoccupation with imagined defect; mirror checking
- Hoarding disorder: persistent difficulty discarding possessions
10. Substance use disorders (MUST KNOW)
- Criteria: impaired control, social impairment, risky use, pharmacological (tolerance, withdrawal)
- Alcohol: withdrawal (tremor, seizures, delirium tremens), detoxification with benzodiazepines, thiamine (Wernicke-Korsakoff prevention), naltrexone/acamprosate/disulfiram
- Opioids: withdrawal (autonomic storm, mydriasis, diarrhea), naloxone for overdose, methadone/buprenorphine maintenance
- Stimulants (cocaine, amphetamine): cardiac, psychiatric
- Tobacco: nicotine replacement, varenicline, bupropion
11. Neurocognitive disorders (MUST KNOW)
- Delirium: acute, fluctuating, attention impairment, reversible — treat the cause
- Dementia: chronic, progressive, memory + ≥1 domain — Alzheimer's (most common), vascular, Lewy body, frontotemporal
- Mild cognitive impairment (MCI): cognitive decline not meeting dementia criteria
12. Suicide risk assessment (MUST KNOW)
- Risk factors: prior attempt (strongest), male sex, older age, depression/bipolar, substance use, psychosis, hopelessness, chronic pain/illness, social isolation, access to means
- Assessment: ideation, plan, means, intent, timeframe, protective factors (family, faith, reasons for living)
- Management: safety plan, remove means, hospitalization if imminent, treat underlying disorder, follow-up
- In China, suicide is a significant cause of death — one of the leading causes in the young
High-Yield Points
- 4 D's of abnormality: Deviance, Dysfunction, Distress, Danger
- Diathesis-stress model; biopsychosocial model
- Schizophrenia: positive (delusions, hallucinations, disorganized) + negative (avolition, alogia, anhedonia, flat affect); ≥6 months; antipsychotics (2nd gen first-line)
- Mania: DIG FAST (Distractibility, Insomnia, Grandiosity, Flight of ideas, Activity, Speech, Thoughtlessness)
- Bipolar: lithium (0.6-1.2), avoid antidepressant monotherapy
- Personality disorders: Cluster A (odd), B (dramatic), C (anxious); BPD = instability + splitting + self-harm → DBT
- Somatic symptom, illness anxiety, conversion (la belle indifférence), factitious vs malingering
- Anorexia: BMI <18.5, fear of weight gain, refeeding syndrome risk
- OCD: ERP + SSRIs
- Suicide: prior attempt strongest risk factor; safety plan + remove means
- Delirium = acute/fluctuating; dementia = chronic/progressive
Topic Summary
Abnormal psychology defines disorders by the 4 D's (deviance, dysfunction, distress, danger) within the biopsychosocial and diathesis-stress frameworks, classified by DSM-5. Key categories: schizophrenia (positive: delusions/hallucinations/disorganization; negative: avolition/alogia/anhedonia — antipsychotics), bipolar (mania = DIG FAST; lithium first-line), depressive & anxiety (Ch10), personality disorders (Clusters A/B/C; BPD → DBT), somatic symptom & related (conversion with la belle indifférence; factitious vs malingering), eating (anorexia — refeeding risk; bulimia — hypokalemia), OCD (ERP + SSRIs), substance use (alcohol withdrawal/opioid overdose), and neurocognitive (delirium vs dementia). Suicide risk assessment (prior attempt strongest, safety plan, remove means) is a core clinical duty. The exam pairs each disorder with its key features, mnemonics, and first-line treatment.
LMCHK OSCE Practice
- Mental state examination (MSE): appearance, behavior, speech, mood/affect, thought form/content, perception (hallucinations), cognition, insight — the core psychiatric assessment.
- Psychosis assessment: delusions (fixed false beliefs), hallucinations (auditory — command/commenting), thought disorder; rule out organic cause (delirium, drugs).
- Mania recognition: elevated mood, pressured speech, decreased need for sleep, grandiosity, poor judgment (DIG FAST) — lithium level check.
- Borderline personality crisis: acute self-harm/suicidality — safety plan, short-term containment, refer for DBT; avoid splitting staff.
- Eating disorder assessment: BMI, eating behaviors, purging; check electrolytes (hypokalemia), ECG (QT); refeeding syndrome prevention (phosphate).
- Suicide risk: ask specifically about thoughts, plan, means, intent; involve family; hospitalize if imminent.
- Alcohol withdrawal: tremor, sweats, hallucinations, seizures → CIWA score, benzodiazepine detox, thiamine (IV), folate.
- Opioid overdose: respiratory depression, pinpoint pupils → naloxone; monitor for withdrawal.
- Delirium vs dementia: acute onset + fluctuation + attention → delirium (treat cause); chronic + memory → dementia.
- Somatic symptom patient: validate symptoms, avoid over-investigation, CBT referral, treat comorbidity.
- Stigma reduction: explain mental illness as a treatable medical condition (biopsychosocial), encourage help-seeking.
- Antipsychotic side effects counselling: EPS, metabolic syndrome, tardive dyskinesia — monitoring plan.